← Back to Search

Behavioural Intervention

Gait training with exoskeleton resistance for Sarcopenia

Q: Is the process of enrolling participants currently underway for this clinical trial?

According to the details provided on clinicaltrials.gov, patient recruitment is ongoing for this trial. The study was first listed on 2/1/2023 and most recently revised on 2/21/2024.

Q: Does this research involve individuals who are in their ninth decade of life or older?

Individuals aged between 65 and 85 years old are eligible to partake in this trial as per the stipulated age requirements.

Q: What is the current number of individuals receiving treatment within this specific clinical trial?

Affirmative. The details on clinicaltrials.gov indicate that this research study is actively seeking participants. Originally posted on February 1st, 2023, it was most recently updated on February 21st, 2024. The trial aims to enroll eight patients from a single site.

Phase < 1

Recruiting

Research Sponsored by Northern Arizona University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age between 65 and 85 years old, inclusive

Able to walk at least 30 feet with or without a walking aid

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 day

Awards & highlights

Study Summary

This trial aims to help older people move better by testing if wearing special devices on their ankles can improve their walking ability. They will also see if using these devices on the ankle, knee, or hip

Who is the study for?

This trial is for older adults with sarcopenia, which means they've lost muscle mass and strength. Participants should be interested in improving their walking ability. Specific eligibility details are not provided, so generally healthy older adults looking to enhance mobility may apply.Check my eligibility

What is being tested?

The study is testing two approaches: one where participants walk with added resistance at the ankle to strengthen muscles, and another where they use wearable devices that assist movement at the ankle, knee, or hip to improve walking.See study design

What are the potential side effects?

Since this trial involves physical training and wearable devices for assistance, potential side effects might include muscle soreness or fatigue from resistance exercises and discomfort or skin irritation from wearing the devices.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 65 and 85 years old.

Select...

I can walk at least 30 feet by myself or with help.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 day

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 day

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

6MWT

Metabolic power

Plantar flexor strength

Trial Design

1Treatment groups

Experimental Treatment

Group I: Gait training with exoskeleton resistanceExperimental Treatment1 Intervention

Participants will complete 20-30 minutes of ankle resistance training on each visit. This will involve walking on a treadmill with stance phase ankle resistance and biofeedback.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Northern Arizona UniversityLead Sponsor

32 Previous Clinical Trials

6,714 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the process of enrolling participants currently underway for this clinical trial?

"According to the details provided on clinicaltrials.gov, patient recruitment is ongoing for this trial. The study was first listed on 2/1/2023 and most recently revised on 2/21/2024."

Answered by AI

Does this research involve individuals who are in their ninth decade of life or older?

"Individuals aged between 65 and 85 years old are eligible to partake in this trial as per the stipulated age requirements."

Answered by AI

What is the current number of individuals receiving treatment within this specific clinical trial?

"Affirmative. The details on clinicaltrials.gov indicate that this research study is actively seeking participants. Originally posted on February 1st, 2023, it was most recently updated on February 21st, 2024. The trial aims to enroll eight patients from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Ankle Assistance and Resistance in Older Adults

2023. "Ankle Assistance and Resistance in Older Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06284525.

All > Sarcopenia